Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 73
Filtrar
Más filtros

Intervalo de año de publicación
1.
Biomed Res Int ; 2021: 5510174, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34195261

RESUMEN

INTRODUCTION: Illicium verum commonly known as star anise has been widely used in many Asian countries for pharmaceutical treatment for many diseases. The aim of the present study was to investigate the anti-inflammatory, astringent, and antimicrobial properties of an Illicium verum mouthwash. METHODS: The present double blinded randomized clinical trial was conducted on fifty subjects, divided into groups A and B. Illicium verum mouthwash (group A) and placebo (group B) were provided to subjects for 21 days; after 14 days, washout period mouthwashes were switched as per crossover design between groups for 21 days. The gingival index (GI), papillary bleeding index (PBI), and oral microbial count were recorded at each stage of study. RESULTS: The significant intragroup difference was observed, before crossover in group A and after crossover in group B for GI, PBI, and oral microbial count at different stages of study. On comparing both group A and group B at the first and second follow-up for GI, PBI, and oral microbial count, a statistically significant difference (p < 0.05) was observed. A statistically highly significant mean intergroup and intragroup difference was seen for all the clinical parameters at different stages of study. CONCLUSION: The study revealed that the Illicium verum/star anise has potent antibacterial, anti-inflammatory, and astringent properties.


Asunto(s)
Antiinfecciosos/farmacología , Antiinflamatorios/farmacología , Astringentes/farmacología , Illicium/metabolismo , Boca/efectos de los fármacos , Adolescente , Adulto , Factores de Edad , Estudios Cruzados , Método Doble Ciego , Femenino , Humanos , Masculino , Medicina Ayurvédica , Mucosa Bucal/microbiología , Antisépticos Bucales , Índice Periodontal , Extractos Vegetales/farmacología , Proyectos de Investigación , Resultado del Tratamiento , Adulto Joven
2.
Dermatol Surg ; 47(6): 780-784, 2021 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-33867466

RESUMEN

BACKGROUND: Most patients with scleroderma suffer from microstomia, which can have debilitating consequences on their quality of life. Unfortunately, treatment options remain limited. No specific guidelines exist; hence, microstomia remains a challenge to treat in this patient population. OBJECTIVE: This review aims to evaluate the different medical and surgical treatment modalities currently available for microstomia in patients with scleroderma and make recommendations for future research. MATERIALS AND METHODS: A search of PubMed, Ovid MEDLINE, and Ovid Embase was conducted to identify articles discussing the treatment of microstomia in scleroderma. Twenty articles discussing surgical therapy and one article discussing medical therapy were reviewed. RESULTS: Mostly because of a scarcity of high-level evidence, no individual therapy has documented long-term efficacy. Some treatments demonstrate positive results and warrant further research. CONCLUSION: Given the variability of results, specific recommendations for the treatment of microstomia in patients with scleroderma are difficult to establish. A multifaceted approach that includes surgical and medical therapy is likely the best option to improve oral aperture in this patient population. Surgical treatments such as neurotoxins, autologous fat grafting, and ultraviolet A1 phototherapy may hold the most potential for improvement.


Asunto(s)
Microstomía/terapia , Calidad de Vida , Esclerodermia Sistémica/complicaciones , Tejido Adiposo/trasplante , Músculos Faciales/efectos de los fármacos , Músculos Faciales/inervación , Músculos Faciales/efectos de la radiación , Músculos Faciales/cirugía , Humanos , Microstomía/etiología , Microstomía/psicología , Boca/efectos de los fármacos , Boca/efectos de la radiación , Boca/cirugía , Neurotoxinas/administración & dosificación , Esclerodermia Sistémica/terapia , Trasplante Autólogo , Resultado del Tratamiento , Terapia Ultravioleta/métodos
3.
Sci Rep ; 10(1): 22312, 2020 12 18.
Artículo en Inglés | MEDLINE | ID: mdl-33339861

RESUMEN

Plants may contain beneficial or potentially dangerous substances to humans. This study aimed to prepare and evaluate a new drug delivery system based on a glass-ionomer-Brazilian pepper extract composite, to check for its activity against pathogenic microorganisms of the oral cavity, along with its in vitro biocompatibility. The ethanolic Brazilian pepper extract (BPE), the glass-ionomer cement (GIC) and the composite GIC-BPE were characterized by scanning electron microscopy, attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), and thermal analysis. The BPE compounds were identified by UPLC-QTOF-MS/MS. The release profile of flavonoids and the mechanical properties of the GIC-BPE composite were assessed. The flavonoids were released through a linear mechanism governing the diffusion for the first 48 h, as evidenced by the Mt/M∞ relatively to [Formula: see text], at a diffusion coefficient of 1.406 × 10-6 cm2 s-1. The ATR-FTIR analysis indicated that a chemical bond between the GIC and BPE components may have occurred, but the compressive strength of GIC-BPE does not differ significantly from that of this glass-ionomer. The GIC-BPE sample revealed an ample bacterial activity at non-cytotoxic concentrations for the human fibroblast MRC-5 cells. These results suggest that the prepared composite may represent an alternative agent for endodontic treatment.


Asunto(s)
Anacardiaceae/química , Cementos de Ionómero Vítreo/síntesis química , Boca/efectos de los fármacos , Extractos Vegetales/química , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Brasil , Fuerza Compresiva , Frutas/química , Cementos de Ionómero Vítreo/química , Cementos de Ionómero Vítreo/farmacología , Humanos , Ensayo de Materiales , Microscopía Electrónica de Rastreo , Boca/química , Boca/microbiología , Extractos Vegetales/farmacología , Espectroscopía Infrarroja por Transformada de Fourier
4.
J Altern Complement Med ; 26(9): 799-806, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32924561

RESUMEN

Objectives: To evaluate (1) the effect of a salivary substitute prepared using chamomile (Matricaria chamomilla L.) flower and flax (Linum usitatissimum L.) seed to relieve Primary burning mouth syndrome (BMS) symptoms, (2) their effect on the inhibition of matrix metallopeptidase 2 (MMP2) and MMP9 metalloproteinases, and (3) their potential cellular cytotoxic effect. Subjects: 40 women aging >40 years with diagnosis of primary BMS. Settings/Location: Center of Diagnosis of Diseases of the Mouth, Federal University of Pelotas, Brazil. Design: This was an open clinical trial where primary BMS patients used the homemade salivary. At the first appointment, after 30 and 60 days, the authors evaluated the pattern and intensity of BMS and xerostomia symptoms, and then determined and compared the unstimulated salivary flow rate (SFR), viscosity, and salivary pH. MMP2 and MMP9 activities in saliva and cytotoxicity were assessed using different concentrations of chamomile flower and flax seed separately. Interventions: Subjects used the homemade salivary substitute for 3 months and were instructed to rinse their mouth three to four times daily for 1 min. Outcome measures: A numeric rating scale to evaluate the intensity of burning sensation and xerostomia symptoms, salivary flow rate (SFR) to determine salivary volume, dynamic rheology technique for viscosity and a digital meter for salivary pH. MMP2 and MMP9 activities in saliva and cytotoxicity were assessed by zymography and cell viability assay respectively. Results: After treatment, severity of BMS symptoms decreased, the SFR increased, salivary viscosity decreased, and severity of xerostomia sensation (in patients who reported having this symptom) improved (p < 0.05). Chamomile flower and flax seed had no effect on inhibiting MMP2 and MMP9 activities, and neither showed cellular cytotoxic effects. Conclusion: This homemade salivary substitute is an economical, viable, easily manipulated, noncytotoxic, and a practical alternative to relieve BMS symptoms.


Asunto(s)
Síndrome de Boca Ardiente/terapia , Manzanilla , Lino , Matricaria , Extractos Vegetales/uso terapéutico , Saliva , Xerostomía/terapia , Anciano , Anciano de 80 o más Años , Femenino , Flores , Humanos , Persona de Mediana Edad , Boca/efectos de los fármacos , Boca/patología , Fitoterapia , Extractos Vegetales/farmacología , Semillas
5.
Biomolecules ; 10(9)2020 08 25.
Artículo en Inglés | MEDLINE | ID: mdl-32854243

RESUMEN

Pomegranate (Punica granatum) is a well-established folklore medicine, demonstrating benefits in treating numerous conditions partly due to its antimicrobial and anti-inflammatory properties. Such desirable medicinal capabilities are attributed to a high hydrolysable tannin content, especially punicalagin. However, few studies have evaluated the abilities of pomegranate to promote oral healing, during situations such as periodontal disease or trauma. Therefore, this study evaluated the antioxidant and in vitro gingival wound healing effects of pomegranate rind extract (PRE) and punicalagin, alone and in combination with Zn (II). In vitro antioxidant activities were studied using DPPH and ABTS assays, with total PRE phenolic content measured by Folin-Ciocalteu assay. PRE, punicalagin and Zn (II) combination effects on human gingival fibroblast viability/proliferation and migration were investigated by MTT assay and scratch wounds, respectively. Punicalagin demonstrated superior antioxidant capacities to PRE, although Zn (II) exerted no additional influences. PRE, punicalagin and Zn (II) reduced gingival fibroblast viability and migration at high concentrations, but retained viability at lower concentrations without Zn (II). Fibroblast speed and distance travelled during migration were also enhanced by punicalagin with Zn (II) at low concentrations. Therefore, punicalagin in combination with Zn (II) may promote certain anti-inflammatory and fibroblast responses to aid oral healing.


Asunto(s)
Encía/efectos de los fármacos , Taninos Hidrolizables/administración & dosificación , Extractos Vegetales/administración & dosificación , Granada (Fruta) , Cicatrización de Heridas/efectos de los fármacos , Zinc/administración & dosificación , Antioxidantes/administración & dosificación , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/fisiología , Encía/citología , Encía/fisiología , Humanos , Técnicas In Vitro , Boca/citología , Boca/efectos de los fármacos , Boca/lesiones , Fenoles/administración & dosificación , Fenoles/análisis , Extractos Vegetales/química , Granada (Fruta)/química , Cicatrización de Heridas/fisiología
6.
Asian Pac J Cancer Prev ; 21(8): 2447-2452, 2020 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-32856877

RESUMEN

OBJECTIVE: Oral submucous fibrosis (OSF) is the premalignant disorder associated with fibrosis and epithelial atrophy. Areca Nut (AN) is the most significant risk factors for OSF. However, the molecular mechanism behind AN induced OSF remains unclear, and there exists no effective treatment for the malignant disorder. We aimed to investigate whether AN-extract causes epithelial-mesenchymal transition (EMT) in oral keratinocytes, and evaluated the therapeutic potential of antioxidants. METHODS: The HPV16 E6/E7-transfected immortalized human oral keratinocytes (IHOK) were employed in the present study. For the preparation of AN-extract, dried AN was dissolved in distilled water overnight. The solution was centrifuged and the supernatant was collected for further use. For the determination of change in cytokine levels, ELISA was performed. To investigate EMT-related protein expression and phenotype, immunoblot and immunofluorescence were performed. RESULTS: Among tumor-promoting cytokines (Gro-α, IL-6 and IL-8), IL-6 was remarkably increased by AN in IHOK. AN-extract induced EMT phenotypes, such as cell elongation, up-regulation of vimentin and snail. After treatment with neutralizing antibody of IL-6, AN-induced snail expression was reduced remarkably. Collectively, AN-extract induced IL-6 expression and mediated EMT. The use of antioxidants (EGCG, glutathione and NAC) significantly reduced IL-6 expression in AN-treated IHOK. Also, AN-decreased E-cadherin and increased vimentin were reversed by antioxidants, indicating that the effectiveness of antioxidants in inhibiting IL-6-induced EMT by AN. CONCLUSION: AN promotes EMT and antioxidants interrupt AN-induced-EMT in oral keratinocytes. Consequently, it is proposed that antioxidants could prevent AN-induced carcinogenesis and function as a prototype for developing therapeutic interventions of OSF.
.


Asunto(s)
Antioxidantes/farmacología , Areca/química , Carcinogénesis/efectos de los fármacos , Queratinocitos/efectos de los fármacos , Boca/efectos de los fármacos , Extractos Vegetales/efectos adversos , Sustancias Protectoras/farmacología , Carcinogénesis/inducido químicamente , Carcinogénesis/patología , Células Cultivadas , Humanos , Queratinocitos/patología , Boca/patología , Nueces/química
7.
Pharm Dev Technol ; 25(2): 159-167, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31623500

RESUMEN

Films of gellan gum:pectin blends were prepared by solvent casting method. Gellan gum:pectin mass ratios were varied (4:1; 1:1; 1:4) at different concentrations (3% or 4%) and glycerol was used as plasticizer (1 or 2%). The films were thin (18-30 µm), translucent, flexible, and homogeneous. The surface pH was suitable for buccal application. All films reached high mechanical resistance and the mucoadhesive ability of them was evidenced. High ratio of gellan gum improved the mechanical resistance and the mucoadhesion of the films as well as the control of drug release rates. The films did not disintegrate in simulate saliva up to 24 h and curcumin release could be sustained up to 12 h. The set of data evidence that the films designed in this work represent a potential platform for buccal drug delivery.


Asunto(s)
Pectinas/química , Polisacáridos Bacterianos/química , Administración Bucal , Curcumina/administración & dosificación , Curcumina/química , Preparaciones de Acción Retardada/química , Sistemas de Liberación de Medicamentos/métodos , Liberación de Fármacos/efectos de los fármacos , Boca/efectos de los fármacos , Mucosa Bucal/efectos de los fármacos , Plastificantes/química
8.
Niger J Clin Pract ; 22(10): 1378-1387, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31607727

RESUMEN

OBJECTIVE: The objective was to determine the antibacterial activity of Salvadora persica extract against bacteria isolated from dental plaque of patients. MATERIALS AND METHODS: Out of 40 different clinical specimens collected from patients suffering from plaque-induced gingivitis, 12 Staphylococcus aureus and 8 Streptococcus sp. isolates were recovered. The isolates were screened for their biofilm-forming capacity using tissue culture plate (TCP), tube method (TM), and congo red agar (CRA) method. Antibacterial activity of methanolic S. persica extract as well as of commercial antimicrobials against tested isolates was performed. High-performance liquid chromatography-mass spectrometry (HPLC-MS) and gas chromatography-MS (GC-MS) analysis were performed for S. persica crude extract and its volatile oil, respectively, to determine their constituents. RESULTS: Out of 20 isolates, 80%, 85%, and 90% showed positive results using TM, CRA, and TCP, respectively. The highest antimicrobial activity of methanolic S. persica extract was observed at 200 mg/ml. HPLC-MS analysis shows many polyphenols in S. persica extract such as Chrysin-8-c-ß-D-glucopyranoside, ferulic acid, gallic acid, and stigmasterol. Chemical composition of the essential oil of S. persica was determined by GC-MS yield; a mixture of monoterpene and hydrocarbons. The major compounds were butylated hydroxytoluene followed by benzene (isothiocyanatomethyl). CONCLUSION: Methanolic extract of S. persica had significant antibacterial effect against S. aureus and Streptococcus sp. isolates, and it may be gave a good alternative method for controlling oral pathogen.


Asunto(s)
Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Placa Dental/microbiología , Gingivitis/microbiología , Boca/efectos de los fármacos , Extractos Vegetales/farmacología , Salvadoraceae/química , Staphylococcus aureus/efectos de los fármacos , Adulto , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Bacterias/crecimiento & desarrollo , Bacterias/aislamiento & purificación , Bacterias/patogenicidad , Cromatografía Líquida de Alta Presión , Caries Dental/microbiología , Femenino , Cromatografía de Gases y Espectrometría de Masas , Gingivitis/tratamiento farmacológico , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Boca/microbiología , Extractos Vegetales/química , Streptococcus/efectos de los fármacos
9.
Complement Ther Med ; 43: 81-84, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30935560

RESUMEN

OBJECTIVES: To assess the value of bee products with respect to antiviral efficacy against herpes viruses. DESIGN: A systematic review was done using the JUSTfind System of the Justus-Liebig-University Gießen and Scopus. RESULTS: Three trials on honey and 6 trials on propolis were conducted. Each trial provided evidence that these two bee products are interesting alternatives to acyclovir, especially propolis, which was found to be superior to acyclovir in 4 trials. CONCLUSIONS: The evidence from these trials suggests that propolis is the best of all natural possibilities in the treatment of herpetic skin lesions, especially those related to HSV-1. Future studies should analyse if propolis could be an adjunct to treatment with acyclovir. For lesions in the oral cavity, honey could be an interesting alternative.


Asunto(s)
Antivirales/farmacología , Abejas/metabolismo , Vesícula/tratamiento farmacológico , Genitales/efectos de los fármacos , Boca/efectos de los fármacos , Simplexvirus/efectos de los fármacos , Piel/efectos de los fármacos , Aciclovir/farmacología , Animales , Vesícula/virología , Genitales/virología , Humanos , Boca/virología , Própolis/farmacología , Piel/virología
10.
Clin Exp Dent Res ; 5(1): 7-13, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30847228

RESUMEN

Sichuan pepper is a plant belonging to the genus Zanthoxylum and family rue. To evaluate whether Sichuan pepper oil boosts saliva secretion using an encapsulated food product containing the oil in subjects presenting with mouth dryness. We evaluated subjective symptoms that changed with a decrease in salivary secretion in the subjects by evaluating the number of Candida colonies and by conducting interviews. The study results demonstrated that salivary secretion increased by 39.4% ± 37.6% after single ingestion of the product, and an additional 8.7% ± 13.2% and 6.3% ± 31.2% following continuous ingestion over 2 and 4 weeks, respectively. These findings suggested that the product rapidly promotes and maintains salivation. Regarding the proliferation of Candida colonies in subjects with mouth dryness, a negative correlation was observed between Candida colony number and salivary secretion quantity. Additionally, interviews revealed that subjective symptoms, such as mouth dryness, discomfort and pain in the mouth, difficulty swallowing the saliva, and feeling of stickiness in the mouth, improved shortly after single ingestion of the product, and mouth dryness was reduced by continuous consumption of the product. These findings indicated that the product studied promotes rapid salivary secretion, is effective in reducing the number of oral Candida colonies, and improves subjective symptoms such as mouth dryness.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Fitoterapia , Salivación/efectos de los fármacos , Xerostomía/tratamiento farmacológico , Zanthoxylum , Adulto , Anciano , Anciano de 80 o más Años , Candida/aislamiento & purificación , Deglución/efectos de los fármacos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Boca/efectos de los fármacos , Boca/microbiología , Aceites de Plantas/uso terapéutico , Saliva/efectos de los fármacos , Encuestas y Cuestionarios , Xerostomía/microbiología , Adulto Joven
11.
Biochem Biophys Res Commun ; 503(4): 2301-2305, 2018 09 18.
Artículo en Inglés | MEDLINE | ID: mdl-29964016

RESUMEN

We attempted to identify mouse bitter taste receptors, Tas2rs, that respond to tea catechins. Among representative tea catechins, avoidance behavior of mice to (-)-epicatechin gallate (ECg) was the strongest, followed by (-)-epigallocatechin gallate (EGCg). Therefore, we measured ECg response using Tas2rs-expressing cells. Among the 35 members of Tas2r family, Tas2r108, 110, 113, 125, and 144 responded to ECg. Among these receptors, Tas2r113 and 125 also responded to EGCg. Because the response profiles of Tas2r125 were consistent with the results of the behavior assays, it was considered that Tas2r125 functions as the main receptor for detecting bitterness of tea catechins in the oral cavity. To determine the involvement of Tas2rs in the physiological action of catechins, mRNA expression of 5 Tas2rs was investigated in various tissues. Because mRNA expression of Tas2r108 was observed in some tissues including the gastrointestinal tract, it may be envisaged that Tas2r108 plays a part in exerting the physiological action of ECg. Tas2r125 expression was not observed in any of the tested tissues except the circumvallate papillae. Therefore, Tas2r125 was considered to mainly function in the events of catechin reception in the oral cavity.


Asunto(s)
Reacción de Prevención/efectos de los fármacos , Catequina/fisiología , Boca/química , Receptores de Superficie Celular/fisiología , Receptores Acoplados a Proteínas G/fisiología , Gusto , Té/química , Animales , Catequina/análogos & derivados , Catequina/farmacología , Ratones , Boca/efectos de los fármacos , ARN Mensajero/análisis , Receptores de Superficie Celular/genética , Receptores Acoplados a Proteínas G/genética
13.
Complement Ther Clin Pract ; 30: 6-13, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29389481

RESUMEN

BACKGROUND: Over 80% of head and neck cancer patients suffer from radiotherapy-induced xerostomia (dry mouth). Xerostomia affects cancer patients' quality of life, and xerostomia sometimes persists throughout the patients' lifetime. This review aimed to evaluate the effectiveness and safety of Chinese herbs in relieving radiotherapy induced xerostomia. METHODS: Systematic searches were conducted on 6 databases (English and Chinese). Studies published up till May 2017 were considered for inclusion. RESULTS: A final 14 RCTs (total 994 head and neck cancer patients undergoing radiotherapy) compared Chinese herbs with no herbs, were included in analysis. Very low to moderate quality of evidence found Chinese herbal treatment may relief radiotherapy-induced xerostomia and other related complications (such as oral mucositis and loss of appetite) in head and neck cancer patients. CONCLUSION: There is limited evidence that Chinese herbal treatment may relief radiotherapy-induced xerostomia and other related complications in head and neck cancer patients.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Neoplasias de Cabeza y Cuello/radioterapia , Boca/efectos de los fármacos , Calidad de Vida , Xerostomía/etiología , Medicamentos Herbarios Chinos/uso terapéutico , Femenino , Humanos , Masculino , Boca/patología , Saliva , Xerostomía/tratamiento farmacológico
14.
Phytother Res ; 32(4): 586-596, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29193389

RESUMEN

Copaifera ssp. produces an oil-resin that presents antiinflammatory, antitumor, antiseptic, germicidal, antifungal, and antibacterial activity. This systematic review aimed to analyze the antimicrobial action of Copaiba oil against oral pathogens, when compared to that of control substances. A search on Medline/PubMed, LILACS, SciELO, EMBASE, and SCOPUS databases were performed up to March 2017. To be included, the studies needed to perform any antimicrobial activity essay, using copaiba oil and a control substance. The antimicrobial effect of each substance, in each study, was extracted. Eleven studies were included, and several copaiba species were used. All studies showed that copaiba oil, regardless of its species, presented a bactericidal and/or bacteriostatic effect in in vitro analyzes. Only one study showed that the antimicrobial effect of the Copaifera officinalis was similar to the one found in chlorhexidine. A higher risk of bias was detected in most of the included studies. The studies demonstrated that the antimicrobial activity of copaiba oil, in most cases, is lower than chlorhexidine, which is considered the gold standard. However, there is great potential against oral bacteria. Further high quality studies are warranted in order to assess the efficacy of copaiba oil on oral pathogens.


Asunto(s)
Antiinfecciosos/uso terapéutico , Fabaceae/química , Boca/efectos de los fármacos , Aceites Volátiles/química , Aceites de Plantas/química , Antiinfecciosos/farmacología , Boca/microbiología , Patología Bucal
15.
Cancer Prev Res (Phila) ; 11(3): 157-164, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29158340

RESUMEN

We previously showed that metabolic activation of the environmental and tobacco smoke constituent dibenzo[a,l]pyrene (DB[a,l]P) to its active fjord region diol epoxide (DB[a,l]PDE) is required to induce DNA damage, mutagenesis, and squamous cell carcinoma (SCC) in the mouse oral cavity. In contrast to procarcinogens, which were employed previously to induce SCC, DB[a,l]PDE does not require metabolic activation to exert its biological effects, and thus, this study was initiated to examine, for the first time, whether black raspberry powder (BRB) inhibits postmetabolic processes, such as DNA damage, mutagenesis, and tumorigenesis. Prior to long-term chemoprevention studies, we initially examined the effect of BRB (5% added to AIN-93M diet) on DNA damage in B6C3F1 mice using LC/MS-MS and on mutagenesis in the lacI gene in the mouse oral cavity. We showed that BRB inhibited DB[a,l]PDE-induced DNA damage (P < 0.05) and mutagenesis (P = 0.053) in the oral cavity. Tumor incidence in the oral cavity (oral mucosa and tongue) of mice fed diet containing 5% BRB was significantly (P < 0.05) reduced from 93% to 66%. Specifically, the incidence of benign tumor was significantly (P < 0.001) reduced from 90% to 31% (62% to 28% in the oral cavity and 28% to 2% in the tongue), a nonsignificant reduction of malignant tumors from 52% to 45%. Our preclinical findings demonstrate for the first time that the chemopreventive efficacy of BRB can be extended to direct-acting carcinogens that do not require phase I enzymes and is not just limited to procarcinogens. Cancer Prev Res; 11(3); 157-64. ©2017 AACR.


Asunto(s)
Carcinogénesis/efectos de los fármacos , Aductos de ADN/efectos de los fármacos , Boca/efectos de los fármacos , Mutagénesis/efectos de los fármacos , Extractos Vegetales/farmacología , Rubus/química , Animales , Benzopirenos , Carcinogénesis/inducido químicamente , Carcinogénesis/patología , Aductos de ADN/metabolismo , Daño del ADN/efectos de los fármacos , Compuestos Epoxi , Femenino , Ratones , Ratones Endogámicos C57BL , Boca/metabolismo , Boca/patología , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/metabolismo , Mucosa Bucal/patología , Neoplasias de la Boca/inducido químicamente , Neoplasias de la Boca/genética , Neoplasias de la Boca/prevención & control , Fitoterapia
16.
Mol Carcinog ; 56(11): 2446-2460, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28618017

RESUMEN

Effective chemoprevention is critical for improving outcomes of oral cancer. As single agents, curcumin and metformin are reported to exhibit chemopreventive properties, in vitro as well as in patients with oral cancer. In this study, the chemopreventive efficacy of this drug combination was tested in a 4-nitro quinoline-1-oxide (4NQO) induced mice oral carcinogenesis model. Molecular analysis revealed a cancer stem cell (CSC)-driven oral carcinogenic progression in this model, wherein a progressive increase in the expression of CSC-specific markers (CD44 and CD133) was observed from 8th to 25th week, at transcript (40-100-fold) and protein levels (P ≤ 0.0001). Chemopreventive treatment of the animals at 17th week with curcumin and metformin indicated that the combination regimen decreased tumor volume when compared to the control arm (0.69+0.03 vs 6.66+2.4 mm3 ; P = 0.04) and improved overall survival of the animals (P = 0.03). Assessment of the molecular status showed an overall downregulation of CSC markers in the treatment arms as compared to the untreated control. Further, in vitro assessment of the treatment on the primary cells generated from progressive stages of 4NQO-induced mice tissue showed a concordant and consistent downregulation of the CSC markers following combination treatment (P < 0.05). The treatment also inhibited the migratory and self-renewal properties of these cells; the effect of which was prominent in the cultures of early dysplastic tissue (P < 0.002). Collectively, our observations suggest that the combination of curcumin and metformin may improve chemopreventive efficacy against oral squamous cell carcinoma through a CSC-associated mechanism.


Asunto(s)
Antineoplásicos/uso terapéutico , Carcinoma de Células Escamosas/prevención & control , Curcumina/uso terapéutico , Hipoglucemiantes/uso terapéutico , Metformina/uso terapéutico , Neoplasias de la Boca/prevención & control , Células Madre Neoplásicas/efectos de los fármacos , 4-Nitroquinolina-1-Óxido , Antígeno AC133/análisis , Animales , Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/patología , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Quimioprevención , Femenino , Receptores de Hialuranos/análisis , Ratones Endogámicos C57BL , Boca/efectos de los fármacos , Boca/patología , Neoplasias de la Boca/inducido químicamente , Neoplasias de la Boca/patología , Células Madre Neoplásicas/patología
17.
Phytother Res ; 31(3): 395-402, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28083890

RESUMEN

Bio-guided fractionation of Aspergillus terreus extract leads to isolation of a novel terpenoidal secondary metabolite. The isolated compound and the total alcoholic extract of Aspergillus terreus showed a remarkable activity against microbial mouth infections; namely, Candida albicans, Lactobacillus acidophilus, Streptococcus gordonii, and S. mutan. Moreover, the Minimum Inhibitory Concentration of the isolated compound was determined and showed low values. The combination of each of the alcoholic extract of A. terreus and the isolated compound Coe-Comfort tissue conditioner inhibited the growth of Candida albicans at concentrations of 500 and 7.81 µg/mL, respectively, Lactobacillus acidophilus at concentrations of 250 and 7.81 µg/mL, respectively, Streptococcus gordonii at concentrations of 1000 and 62.50 µg/mL, respectively, and S. mutans at concentrations of 1000 and 125 µg/mL, respectively. The oral dosing of the extract and the isolated compound did not show any significant effect on the activity of alanine aminotransferase, aspirate aminotransferase, and the levels of blood urea and serum creatinine. Copyright © 2017 John Wiley & Sons, Ltd.


Asunto(s)
Antiinfecciosos/aislamiento & purificación , Antiinfecciosos/uso terapéutico , Aspergillus/química , Crisenos/uso terapéutico , Infecciones/tratamiento farmacológico , Enfermedades de la Boca/tratamiento farmacológico , Animales , Antiinfecciosos/toxicidad , Aspergillus/metabolismo , Candida albicans/efectos de los fármacos , Candida albicans/crecimiento & desarrollo , Crisenos/aislamiento & purificación , Crisenos/toxicidad , Lactobacillus acidophilus/efectos de los fármacos , Lactobacillus acidophilus/crecimiento & desarrollo , Masculino , Pruebas de Sensibilidad Microbiana , Boca/efectos de los fármacos , Boca/microbiología , Ratas , Ratas Wistar , Pruebas de Toxicidad
18.
Physiol Behav ; 167: 180-187, 2016 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-27660032

RESUMEN

Saliva is becoming an increasingly useful research material across multiple fields of inquiry, including biomedical, dental, psychological, nutritional, and food choice research. However, both the flow rate and protein composition of stimulated saliva differ as a function of the collection method. We hypothesized that the context in which a stimulus is presented to participants may alter salivation via top down cognitive effects and/or behavioral changes (i.e., spitting efficiency). We presented participants with one stimulus (commercially available green tea) in two distinct contexts, once where the tea was described as a food item ("tea") and once where it was described as a disgusting non-food item ("rabbit hair extract"). Saliva and the expectorated stimulus were collected following 15s of oral exposure in a crossover design with the identical stimulus presented in both contexts; saliva was also collected for 5min after stimulation while chewing a piece of wax. Participants also completed validated personality instruments to measure food involvement, sensation seeking, sensitivity to reward, and sensitivity to punishment. Our data suggest participants spat out more sample when told they received the 'non-food' stimulus compared to the 'food' stimulus, particularly when they were given the non-food stimulus first. Further, individuals who were higher in sensation seeking spat out more sample during the 'food' condition compared to individuals with lower sensation seeking scores, but this difference was absent in the 'non-food' condition. While consistent with a top down cognitive effect on salivary flow, we believe a greater motivation to spit out the 'non-food' stimulus is a more likely explanation. In either case, it is clear the context in which a stimulus is presented alters how much sample/saliva is expectorated, suggesting context needs to be carefully considered in future work on salivary flow.


Asunto(s)
Anticipación Psicológica , Saliva/metabolismo , Salivación/fisiología , Gusto/fisiología , Análisis de Varianza , Emociones/fisiología , Femenino , Alimentos , Humanos , Masculino , Boca/efectos de los fármacos , Boca/inervación , Salivación/efectos de los fármacos , Tasa de Secreción ,
19.
PLoS One ; 11(9): e0162537, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27606830

RESUMEN

The development of antibacterial drugs to overcome various pathogenic species, which inhabit the oral cavity, faces several challenges, such as salivary flow and enzymatic activity that restrict dosage retention. Owing to their amphipathic nature, antimicrobial peptides (AMPs) serve as the first line of defense of the innate immune system. The ability to synthesize different types of AMPs enables exploitation of their advantages as alternatives to antibiotics. Sustained release of AMPs incorporated in biodegradable polymers can be advantageous in maintaining high levels of the peptides. In this study, four potent ultra-short lipopeptides, conjugated to an aliphatic acid chain (16C) were incorporated in two different biodegradable polymers: poly (lactic acid co castor oil) (PLACO) and ricinoleic acid-based poly (ester-anhydride) (P(SA-RA)) for sustained release. The lipopeptide and polymer formulations were tested for antibacterial activity during one week, by turbidometric measurements of bacterial outgrowth, anti-biofilm activity by live/dead staining, biocompatibility by hemolysis and XTT colorimetric assays, mode of action by fluorescence-activated cell sorting (FACS) and release profile by a fluorometric assay. The results show that an antibacterial and anti-biofilm effect, as well as membrane disruption, can be achieved by the use of a formulation of lipopeptide incorporated in biodegradable polymer.


Asunto(s)
Antibacterianos/farmacología , Materiales Biocompatibles/química , Lipopéptidos/farmacología , Boca/microbiología , Polímeros/química , Animales , Biopelículas/efectos de los fármacos , Aceite de Ricino/farmacología , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Colorimetría , Preparaciones de Acción Retardada , Hemólisis/efectos de los fármacos , Cinética , Ácido Láctico/farmacología , Pruebas de Sensibilidad Microbiana , Boca/efectos de los fármacos , Ovinos
20.
Biomed Res Int ; 2016: 9190814, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27595110

RESUMEN

Maintenance of proper oral hygiene by dental plaque elimination is one of the most important factors affecting the healing process in postoperative oral wounds. Propolis is a substance produced by bees. Ethanolic extract of propolis has bactericidal, fungicidal, anti-inflammatory, and antioxidative properties. Moreover, it can scavenge free radicals. The purpose of this paper is to demonstrate the efficacy of a gel containing 3% of ethanolic extract of Brazilian green propolis (EEP-B) when used for maintaining oral hygiene in patients with postoperative oral mucosal wounds. The hygiene was assessed using API, OHI, and SBI followed by microbiological examinations. The patients were divided into two groups. Group 1 consisted of those who used a gel containing EEP-B for oral hygiene, and group 2 consisted of those who used a gel without EEP-B. Although improved oral hygiene was noted in both groups, the improvement was markedly greater in the group using gel containing EEP-B. Summing up the results of microbiological examinations, EEP-B has beneficial effect on mouth microflora in postoperative period. Propolis preparations used for oral hygiene allow eliminating microorganisms of pathogenic character and physiological flora microorganisms considered as being opportunistic, with no harmful influence on physiological microflora in oral ecosystem.


Asunto(s)
Etanol/química , Geles/uso terapéutico , Fracturas Mandibulares/tratamiento farmacológico , Fracturas Mandibulares/microbiología , Microbiota/efectos de los fármacos , Boca/efectos de los fármacos , Boca/microbiología , Higiene Bucal , Bacterias/efectos de los fármacos , Bacterias/aislamiento & purificación , Índice de Placa Dental , Femenino , Geles/farmacología , Hemorragia/tratamiento farmacológico , Humanos , Masculino , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/microbiología , Própolis/farmacología , Própolis/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA